cosyntropin and Fibromyalgia

cosyntropin has been researched along with Fibromyalgia* in 2 studies

Other Studies

2 other study(ies) available for cosyntropin and Fibromyalgia

Article	Year
[Analgesic action of tetracosactide in chronic pain syndromes]. La Clinica terapeutica, 1981, Sep-30, Volume: 98, Issue:6 Topics: Adrenocorticotropic Hormone; Chronic Disease; Cicatrix; Cosyntropin; Fibromyalgia; Headache; Humans; Neoplasms; Neuralgia; Pain; Palliative Care	1981
[Synthetic ACTH in theumatic diseases: (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1975, Nov-14, Volume: 117, Issue:46 44 patients with acute irritations of degenerative articular diseases and 66 patients with soft tissue rheumatism were treated with Synacthen Depot (tetracosactide hexacetate 1 mg/ml). During the first three days of treatment the patients received an average of 2 ampoulbs Synacthen Depot, then treatment was continued at 3-4 day intervals. In the degenerative joint disease group 86.4% and 89.4% in the group with soft tissue rheumatism became free of complaints or improved with the ACTH treatment. Most of the patients with degenerative joint diseases needed a 4 week treatment; 1/3 of the patients with soft tissue rheumatism were already free of complai Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Aged; Arthritis, Rheumatoid; Cosyntropin; Delayed-Action Preparations; Drug Evaluation; Female; Fibromyalgia; Hip Joint; Humans; Joint Diseases; Knee Joint; Male; Middle Aged; Rheumatic Diseases; Spondylitis	1975

Article

Year

[Analgesic action of tetracosactide in chronic pain syndromes].

La Clinica terapeutica, 1981, Sep-30, Volume: 98, Issue:6

Topics: Adrenocorticotropic Hormone; Chronic Disease; Cicatrix; Cosyntropin; Fibromyalgia; Headache; Humans; Neoplasms; Neuralgia; Pain; Palliative Care

1981

[Synthetic ACTH in theumatic diseases: (author's transl)].

MMW, Munchener medizinische Wochenschrift, 1975, Nov-14, Volume: 117, Issue:46

44 patients with acute irritations of degenerative articular diseases and 66 patients with soft tissue rheumatism were treated with Synacthen Depot (tetracosactide hexacetate 1 mg/ml). During the first three days of treatment the patients received an average of 2 ampoulbs Synacthen Depot, then treatment was continued at 3-4 day intervals. In the degenerative joint disease group 86.4% and 89.4% in the group with soft tissue rheumatism became free of complaints or improved with the ACTH treatment. Most of the patients with degenerative joint diseases needed a 4 week treatment; 1/3 of the patients with soft tissue rheumatism were already free of complai

Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Aged; Arthritis, Rheumatoid; Cosyntropin; Delayed-Action Preparations; Drug Evaluation; Female; Fibromyalgia; Hip Joint; Humans; Joint Diseases; Knee Joint; Male; Middle Aged; Rheumatic Diseases; Spondylitis

1975